Event price: $ 800,000 COP
Pay on line: At the time of your registration you can pay online with credit card and PSE.
Payment in banks:
Present the invoice printed in laser, and approach the following banking entities:
- Banco de Bogotá and its banking correspondents: Almacenes Éxito, Carulla, Surtimax, Súper inter.
Go to the University Cashier and pay with a debit or credit card.
Start date: 08-10-2020
End date: 07-11-2020
Duration: 30.00 hours.
Event city: Medellin
Hours: Starts October 8, 2020 - November 7, 2020, Hours: Thursdays from 5:00 pm - 8:00 pm and Saturdays: 9:00 a.m. - 12:00 m. Place: Online through the Zoom platform.
Event Code: 70089719
To register, you must fill out the form to generate the invoice and make the payment online, banks or in person at the University.
Know the importance of the topics to be addressed during the development of the Course
We share the characteristics or requirements that you must meet to be part of this Course
The modality of the event is Virtual Classroom
The drug development process from discovery to commercialization is long, time consuming, rigorous, and expensive. It is estimated that it can last between 8 to 12 years. Every time a new chemical species with therapeutic possibilities appears, it must undergo a series of tests required by the health authorities to demonstrate not only its efficacy but also its safety. The series of steps and procedures within the development of a drug are usually divided into two moments: the first, known as the preclinical phase, begins with the discovery phase that includes the validation of drug action targets. Subsequent development of potential molecules that interact with the chosen target, and finally the efficacy and safety of these molecules is tested in in vitro and in vivo models. Only then do we proceed to verify the efficacy and safety in humans, which corresponds to the second stage known as the clinical phase. After obtaining sufficient information to demonstrate the safety and efficacy of the new entity, it is finally possible to obtain marketing approval for the new drug. The course of preclinical studies in drug development will allow the student to acquire important elements in the process of developing a drug, they will be synchronous classes where a talk on theoretical foundations and practical exercises will take place, as well as videos where they can see some experimental trials, as well as computational simulations that complement learning. The course will be 30 hours and it raises 10 topics, each one will have a dedication of 6 hours per week. The course is intended for health and life science personnel who have prior knowledge of cell and molecular biology.
Health area personnel
Find out how you can finance your registration in this event.
Find the contents to be dealt with in the Continuing Education Course
Know the skills that you will acquire when taking the Course at our University.
Finance the payment of your registration with SUFI, contact the advisor:
Anderson Acevedo Benitez
Telephone: (57) (4) 604 91 25
Mobile: 301 254 98 44
Payment with Severance:
Check with your fund and severance management company about the requirements to make the payment *.
* Applies for diplomas and certifications.
Topics to be discussed during the activity:
- 1. Introduction Preclinical research, drug development phases
- 2. Prediction of potential molecular targets as a mechanism of action.
- 3. Prediction of in silico properties and construction of compound libraries
- 4. In vitro models of safety and efficacy
- 5. Animal studies, 3R rule (GLP). Toxicity tests (acute, repeated dose and in various species
- 6. Studies of metabolism and binding to transporters
- 7. Toxicokinetics and Pharmacokinetics (ICH S3).
- 8. Strategies to identify risks in early phase clinical trials (EMEA 28,367).
- 9. Preclinical safety of biotechnology (ICH S6). Immunotoxicity Studies (ICH S8).
- 10. Preformulation and characterization studies of active principles.
. Offer the tools and knowledge about the phases of preclinical studies, which allows to identify the stages involved in the design, formulation and development of drugs, their results and their impact on clinical application. In silico models for the search for molecular targets and the construction of compound libraries will be discussed, as well as in vitro and in vivo models on pharmacokinetic, pharmacodynamic, toxicological and safety studies according to international guidelines (ICH and others).